Paragon 28 Retained Earnings (Accumulated Deficit) 2021-2024 | FNA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Paragon 28 retained earnings (accumulated deficit) from 2021 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Paragon 28 Retained Earnings (Accumulated Deficit) 2021-2024 | FNA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$171.9B
Thermo Fisher Scientific (TMO)	$161.4B
Alcon (ALC)	$45.6B
Edwards Lifesciences (EW)	$42B
IDEXX Laboratories (IDXX)	$33.3B
DexCom (DXCM)	$26.9B
IQVIA Holdings (IQV)	$25.4B
STERIS (STE)	$21.8B
Mettler-Toledo (MTD)	$20.9B
Waters (WAT)	$19.1B
SONOVA HOLDING (SONVY)	$17.3B
Fresenius Medical Care AG KGaA (FMS)	$13.9B
Hologic (HOLX)	$12.9B
Sysmex ADR (SSMXY)	$11.8B
Penumbra (PEN)	$10.7B
Globus Medical (GMED)	$9.8B
Masimo (MASI)	$8.2B
Teleflex (TFX)	$6B
Glaukos (GKOS)	$5.2B
Integer Holdings (ITGR)	$4.1B
TransMedics (TMDX)	$3B
PROCEPT BioRobotics (PRCT)	$2.9B
Veracyte (VCYT)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
LivaNova (LIVN)	$1.9B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.5B
Integra LifeSciences Holdings (IART)	$1.2B
Pulse Biosciences (PLSE)	$1.2B
Tandem Diabetes Care (TNDM)	$1.1B